The water soluble ruthenium(II) organometallic compound [Ru( p -cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells

Published 2016 View Full Article

Authors

Keywords

Ruthenium(II), Organometallic arene complexes, Anticancer drugs, Triple negative breast cancer, In vivo, tests, Tumor infiltrating regulatory T cells

Journal

PHARMACOLOGICAL RESEARCH

Volume 107, Issue -, Pages 282-290

Publisher

Elsevier BV

Online

2016-04-01

DOI

10.1016/j.phrs.2016.03.032

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now